—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Natera Inc (NTRA) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

The desk on NTRA

What this diary said about Natera Inc, what it holds and what would change its view — in its own words, dated. Investment diary, not advice.

What we hold

BookPositionSinceResult
AI Buildout 50 shares · average entry $206.25 — +100.0%

Model books as of 25 Sept 2026; wikifolio positions from the official wikifolio data, entries in euros. Results are unrealised, before any exit. A record of what the diary does, not a recommendation to do the same.

Company snapshot — Natera Inc

NTRA in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Natera develops molecular diagnostic tests sold to laboratories, clinics and physicians. Signatera tracks circulating tumour DNA in blood to catch cancer recurrence after treatment, Panorama and Horizon screen pregnancies for genetic conditions, Empower screens for hereditary cancer risk, and Prospera monitors organ-transplant patients for rejection. It also runs Constellation, a cloud platform that licensees use to distribute these tests. It is based in Austin.
Where it sits in the stack
Natera sits in the Longevity & Healthspan sleeve of our HALO Growth 100, the index the diary uses for growth names outside the megacaps. That sleeve groups diagnostics-at-scale businesses with drugmakers and gene-editing platforms on the view that ageing demographics set the pace of demand; Natera is the diagnostics side of that demand, selling volume of tests rather than a drug or device.
Who it is priced against
Closelooknet's peer group places it with the sleeve's diagnostics and biopharma names — Illumina, Eli Lilly, Regeneron, Vertex, Novo Nordisk, Amgen, Zealand Pharma and Gerresheimer — on the shared demographic driver; the market also compares it with Exact Sciences in cancer diagnostics.
Why Closelooknet tracks it
It holds a seat in the HALO Growth 100 and carries a Closelooknet score across seven modules, with momentum the strongest reading and valuation the weakest. The diary's dossier on agentic application software cited Natera alongside Veeva, Tempus AI and Intuitive Surgical when comparing valuation multiples.
What the diary watches
Whether the gap between strong momentum and weak valuation narrows as test volumes and reimbursement trends come through in results.

Natera Inc (NTRA) trades on US exchanges, classified under Healthcare. Constituent of HALO Growth 100.

The Closelooknet company score reads 44/100 composite (momentum 97, quality 22, valuation 6) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelooknet reading that exists for NTRA, from the same nightly bakes the boards use. Research diary readings, not advice.

The Street on this name 1 analyst action on the wire · latest: price target by RBC Capital, 2026-09-25

The Street on this name

Analyst actions and the latest print for NTRA from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Price target RBC Capital — target 460 from 350 Target raised to $460 from $350 (+12.3% to spot) 2026-09-25

1 action on the analyst wire since 2026-08-13: 1 target change. Analyst wire → · Earnings wire →

Who it is priced against HALO Growth 100 · Longevity & Healthspan · 8 names with week and year-to-date

Peer group

HALO Growth 100 · Longevity & Healthspan

GLP-1 leaders, gene-editing platforms, diagnostics-at-scale, biopharma compounders. Demographics writes the demand curve.

Compared against NTRA on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Versus its index HALO Growth 100 — the name, its sleeve and the index over day, week and month

Versus its index

The name against its Closelooknet index and its own sleeve — equal-weight, nightly closes.

HALO Growth 100 · as of 2026-09-25

DayWeekMonth3 months
NTRA+0.9%+11.7%+21.9%+57.5%
Longevity & Healthspan−0.3%+4.5%+0.5%—
HALO Growth 1000.0%+0.2%−7.6%—

Against the index: 11.5 pts ahead on the week, 29.5 pts ahead on the month; against its Longevity & Healthspan sleeve 21.4 pts ahead on the month.

Returns from the index workers’ nightly closes; equal-weight sleeves. A relative reading from the research diary, not advice.

Dividends and capital return no distribution in twelve months

Dividends and capital return

What NTRA pays out and buys back — distributions read from the price series, money terms from the filings.

  • Distributions No cash distribution recorded in the price series over the last three years
  • Share count +9.6% in FY2025 354 m USD of stock-based compensation in the year

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

How it trades on rate days beta 1.22 to TLT · on the worst bond days it moved with the market

How it trades on rate days

How NTRA has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 1.22 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), Natera Inc moved 1.22% on average · correlation 0.24 · higher than 92% of US names
  • Beta, last 3 months 1.12 about the same as over the year
  • On the 10 worst bond days −0.69% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +4.61% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sector × region Health care in US: +1.8% week · −1.3% month · +6.9% quarter · +12.0% yearThe Sector Engine cell this name lives in, from XLV.US; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Natera Inc (NTRA)?

Natera Inc trades as NTRA on the US exchange (US) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is NTRA in a Closelooknet index?

Yes — Natera Inc is a constituent of HALO Growth 100, as of 2026-09-26.

What is Natera Inc's Closelooknet composite score?

44 out of 100, with momentum 97, quality 22 and valuation 6 sub-scores, as of 2026-09-26. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does NTRA trade against its moving averages?

Target raised to $460: RBC Capital lifted its price target to $460 from $350 (2026-09-25). As of 2026-09-24 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How is NTRA doing against its Closelooknet index?

Over the past month Natera Inc is +21.9% against −7.6% for the HALO Growth 100 — 29.5 points ahead of its index, as of 2026-09-25. Its Longevity & Healthspan sleeve is +0.5% over the same month. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.

What does Natera Inc do?

Natera develops molecular diagnostic tests sold to laboratories, clinics and physicians. Signatera tracks circulating tumour DNA in blood to catch cancer recurrence after treatment, Panorama and Horizon screen pregnancies for genetic conditions, Empower screens for hereditary cancer risk, and Prospera monitors organ-transplant patients for rejection. It also runs Constellation, a cloud platform that licensees use to distribute these tests. Closelooknet's peer group places it with the sleeve's diagnostics and biopharma names — Illumina, Eli Lilly, Regeneron, Vertex, Novo Nordisk, Amgen, Zealand Pharma and Gerresheimer — on the shared demographic driver; the market also compares it with Exact Sciences in cancer diagnostics.

Where does Natera Inc sit in the AI build-out?

Natera sits in the Longevity & Healthspan sleeve of our HALO Growth 100, the index the diary uses for growth names outside the megacaps. That sleeve groups diagnostics-at-scale businesses with drugmakers and gene-editing platforms on the view that ageing demographics set the pace of demand; Natera is the diagnostics side of that demand, selling volume of tests rather than a drug or device. It holds a seat in the HALO Growth 100 and carries a Closelooknet score across seven modules, with momentum the strongest reading and valuation the weakest. The diary's dossier on agentic application software cited Natera alongside Veeva, Tempus AI and Intuitive Surgical when comparing valuation multiples.

Does Natera Inc pay a dividend?

No cash distribution shows in Natera Inc’s price series over the last three years. The share count rose 9.6% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

How does Natera Inc trade when bond yields rise?

Over the past year Natera Inc had a beta of 1.22 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 92% of US names. On the 10 sessions in which long bonds fell most it moved −0.69% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

What has Wall Street done on Natera Inc recently?

The most recent analyst action on Natera Inc on the Closelooknet wire is a price target by RBC Capital on 2026-09-25 (target 460 from 350). 1 action on the analyst wire since 2026-08-13: 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

Where has Closelooknet written about Natera Inc?

Natera Inc appears in 1 Closelooknet piece, most recently Dossier: Agentic Application Software: The SaaSpocalypse Map (2026-02-27). What Closelooknet said most recently: Veeva (VEEV) · Tempus AI (TEM) · Natera (NTRA) · Intuitive Surgical (ISRG) Valuation Multiples vs. (Dossier, 2026-02-27). The "Mentioned on Closelooknet" block on this page lists the long reads, the reference entries and the dailies that name it.

What does this page show?

A live price chart with SMA overlays and drawing tools for NTRA, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Mentioned on Closelooknet 1 piece · newest: Dossier, “Agentic Application Software: The SaaSpocalypse Map” (2026-02-27)

Mentioned on Closelooknet

Where NTRA appears in the diary — 1 piece, newest first. Every link is our own writing.

Go deeper

Long reads

Related in the Closelooknet universe

same Closelooknet index seat first, then Diagnostics & Research. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.